Nothing Special   »   [go: up one dir, main page]

Miller et al., 1986 - Google Patents

Regulated expression of the Mac-1, LFA-1, p150, 95 glycoprotein family during leukocyte differentiation.

Miller et al., 1986

View PDF
Document ID
4447914016682035563
Author
Miller L
Schwarting R
Springer T
Publication year
Publication venue
Journal of immunology (Baltimore, Md.: 1950)

External Links

Snippet

The regulation of Mac-1, LFA-1, and p150, 95 expression during leukocyte differentiation was examined. LFA-1 was present on almost all cell types studied. Both Mac-1 and p150, 95 were present on the more mature cells of the myelomonocytic series, but only p150, 95 was …
Continue reading at projects.iq.harvard.edu (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material Not used, see subgroups
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells

Similar Documents

Publication Publication Date Title
Miller et al. Regulated expression of the Mac-1, LFA-1, p150, 95 glycoprotein family during leukocyte differentiation.
Perussia et al. Immune interferon and leukocyte-conditioned medium induce normal and leukemic myeloid cells to differentiate along the monocytic pathway.
Ortaldo et al. Lymphokine-activated killer cells. Analysis of progenitors and effectors.
Dustin et al. Adhesion of T lymphoblasts to epidermal keratinocytes is regulated by interferon gamma and is mediated by intercellular adhesion molecule 1 (ICAM-1).
Gordon Biology of the macrophage
Hemler et al. Glycoproteins of 210,000 and 130,000 mw on activated T cells: cell distribution and antigenic relation to components on resting cells and T cell lines.
Robertson et al. Human natural killer cell adhesion molecules. Differential expression after activation and participation in cytolysis.
Smith et al. Functional subsets of human helper-inducer cells defined by a new monoclonal antibody, UCHL1.
Emerson et al. Developmental regulation of erythropoiesis by hematopoietic growth factors: analysis on populations of BFU-E from bone marrow, peripheral blood, and fetal liver
Rafi-Janajreh et al. Evidence for the involvement of CD44 in endothelial cell injury and induction of vascular leak syndrome by IL-2
Voss et al. Participation of the CD94 receptor complex in costimulation of human natural killer cells
Zola et al. Maturation of human B lymphocytes--studies with a panel of monoclonal antibodies against membrane antigens.
Fitchen et al. Monoclonal antibodies to HLA-A, B, and Ia-like antigens inhibit colony formation by human myeloid progenitor cells.
Dayton et al. Correlation between differentiation, expression of monocyte-specific antigens, and cytotoxic functions in human promyelocytic cell lines treated with leukocyte-conditioned medium.
Todd et al. The modulated expression of Mo5, a human myelomonocytic plasma membrane antigen
US5688690A (en) Human cytotoxic lymphocyte signal transduction surface protein (P38) and monoclonal antibodies thereto
Liu et al. Resistance of cytolytic lymphocytes to perforin-mediated killing. Induction of resistance correlates with increase in cytotoxicity.
EP0160486B1 (en) Monoclonal antibodies
Audran et al. Adhesion molecule expression and response to chemotactic agents of human monocyte-derived macrophages
JPH0753407A (en) Controlling method of immunity response, and chemical related to immunity cell and endothelial cell
US5028424A (en) Antibodies to receptor and antigen for natural killer and non-specific cytotoxic cells
Takeshita et al. Quantitative expression of thrombopoietin receptor on leukaemia cells from patients with acute myeloid leukaemia and acute lymphoblastic leukaemia
Gupta Immune response following surgical trauma
US4728614A (en) Mutant human T cell line producing immunosuppressive factor and method for obtaining such mutants
Letvin et al. In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates: I. Effects of anti-T11 antibodies on the circulating T cell pool